Crescent Capital BDC, Inc. (NASDAQ:CCAP) Short Interest Up 21.2% in February

Crescent Capital BDC, Inc. (NASDAQ:CCAP) was the recipient of a large growth in short interest in February. As of February 28th, there was short interest totalling 103,400 shares, a growth of 21.2% from the February 13th total of 85,300 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average daily trading volume, of 118,900 shares, the days-to-cover ratio is presently 0.9 days.

Crescent Capital BDC Trading Up 0.7 %

Shares of NASDAQ:CCAP opened at $17.67 on Thursday. The company has a 50 day moving average of $18.77 and a 200-day moving average of $18.81. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. The firm has a market cap of $654.89 million, a P/E ratio of 8.88 and a beta of 0.82. Crescent Capital BDC has a twelve month low of $16.81 and a twelve month high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP) last released its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The firm had revenue of $46.40 million during the quarter, compared to analyst estimates of $47.27 million. As a group, analysts anticipate that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently announced a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a dividend of $0.05 per share. The ex-dividend date was Friday, February 28th. Crescent Capital BDC’s payout ratio is currently 84.42%.

Wall Street Analyst Weigh In

A number of research analysts have commented on CCAP shares. Keefe, Bruyette & Woods increased their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Monday, November 25th. Wells Fargo & Company decreased their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, February 21st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $19.20.

Institutional Trading of Crescent Capital BDC

A number of hedge funds and other institutional investors have recently made changes to their positions in CCAP. Montag A & Associates Inc. bought a new stake in Crescent Capital BDC during the fourth quarter worth approximately $35,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Crescent Capital BDC during the 4th quarter worth $39,000. Aquatic Capital Management LLC acquired a new position in shares of Crescent Capital BDC in the 4th quarter worth $129,000. Generation Capital Management LLC acquired a new stake in shares of Crescent Capital BDC during the fourth quarter worth $192,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Crescent Capital BDC during the fourth quarter valued at $218,000. 49.46% of the stock is currently owned by institutional investors.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.